|Property||Resources - Mining|
|Resources - Oil & Gas||Technology|
|Formycon||UK Commercial Property Trust|
|F&C Managed Portfolio Trust||Custodian REIT|
|Target Healthcare REIT||Volt Resources|
|Polypipe||Blancco Technology Group|
e-Therapeutics is a UK-based drug discovery company that has developed a proprietary network pharmacology discovery platform. Its focus is now on commercialisation: securing partners for its discovery and development projects.
EADS is global aerospace and defence group, employing 133,000 people across 170 sites worldwide. It operates four main divisions: Airbus - civil aircraft (67% 2011 revenues); Eurocopter - helicopters (10%); Astrium - satellites and space launch services (10%); and Cassidian - defence systems (12%).
easyHotel is the owner, developer, operator and franchisor of branded hotels. Its strategy is to target the "super budget" segment by marketing "clean, comfortable and safe" hotel rooms to its customers. Three owned hotels currently comprise 390 rooms, and it has 18 franchised hotels with 1,490 rooms.
Ebiquity is an independent marketing performance specialist and a leading provider of a range of business critical data, analysis and consultancy services to advertisers and media owners on an international basis.
Eco City Vehicles has exclusive distribution rights to the Mercedes Vito in the London market. The group provides a one-stop new car, used car and after sales service through its subsidiary KPM Taxis in the London market.
Edinburgh Worldwide Investment Trust’s objective is to achieve long-term capital growth by investing primarily in listed companies globally.
Egdon Resources is an AIM-listed onshore oil and gas exploration company. The group has conventional and unconventional assets in the UK and France.
Elementis is an international speciality chemicals business with primary activities in Specialty Products (FY16: 70% of group net revenue/75% of underlying EBIT before central costs) and Chromium (24%/26%). Specialty Products is further split out into coatings (FY16: c 78% divisional sales), personal care (14%) and energy (8%). Elementis also has a relatively small, single site Surfactants division.
Ellomay Capital owns an international portfolio of power generation assets comprising solar plants in Italy and Spain and a gas-fired power plant in Israel. It operates principally in regulated markets.
EMIS is a clinical software supplier to the primary care market in the UK (supplying over 50% of UK GP practices), a software supplier to UK pharmacies, and through several acquisitions also supplies specialist and acute care software.
Empresaria is a leading international specialist staffing group, covering permanent and temporary recruitment, as well as other staffing services including HR consultancy, training and recruitment process outsourcing.
Endace supplies high-end network traffic monitoring and analysis technology, with a fundamental competence and ability to capture all of the packets flowing through high-speed data networks.
Energy XXI operates or has an interest in six of the 11 largest oil fields in the Gulf of Mexico. The core properties are located in coastal and offshore Louisiana.
Entertainment One (eOne) is a leading international entertainment company that sources, selects and sells films and television content. Its library contains over 40,000 film and TV titles, 4,500 half-hours of TV programming and 45,000 music tracks.
Enwave is an industrial technology company that licenses the rights to proprietary technology that allows foods and pharmaceuticals to be dried more quickly, cheaply, and with better quality than existing freeze drying and air drying technologies.
Epwin supplies functional low-maintenance exterior building products (including windows, doors, roofline and rainwater goods) into a number of UK market segments and is a modest exporter.
Equatorial Resources' flagship iron ore project is Mayoko-Moussondji in the Republic of Congo (Brazzaville), with an overall JORC-compliant resource of 767Mt at 31.9% Fe (including 102Mt of hematite at 40.6% Fe). Having completed a scoping study, the company is looking for a strategic partner to launch a small-scale operation with a short lead time and low capital intensity.
Erytech Pharma is a French orphan oncology company. Its lead product is Graspa, which consists of L-asparaginase encapsulated within a red blood cell. Graspa is in a Phase III trial for acute lymphoblastic leukaemia and a Phase IIb for acute myeloid leukaemia. It is partnered with Recordati in Europe.
Esker provides end-to-end document automation solutions, offering on-premise and on-demand delivery models. The business generates 50% of revenues from Europe, 40% from the US and the remainder from Asia and Australia.
Essentra currently reports in a three-division structure: Health & Personal Care Packaging (38% FY15 revenue: a global provider of packaging and authentication solutions), Filtration Products (36%: a global independent cigarette filter and custom fluid-handling components supplier) and Component Solutions (26%: specialised supply of polymer-based components, tapes and security card systems).
Euromoney Institutional Investor is a leading international B2B media group focused primarily on the international finance, metals and commodities sectors.
European Goldfields is engaged in the acquisition; exploration and development of mineral properties in Greece; Romania and South-East Europe.
Evolving Systems provides activation software and related services primarily to fixed and wireless telecommunications service providers across the globe.
EVR holdings Plc is a start-up Virtual Reality (VR) company, looking to dominate the music events space in Virtual Reality. They have contracts with a number of live events companies, with artists and are in discussions with the music majors to secure exclusive rights to record and broadcast VR content on a hardware agnostic basis.
Exoma is a junior oil and gas explorer that operates five exploration permits totalling 27,000 km2 in the Galilee and Eromanga Basins in central Queensland. It has also been selected as the preferred tender in four blocks adjacent to its existing permits.
e2v develops, manufactures and sells RF power solutions, high-performance imaging solutions and high-reliability semiconductor solutions to the medical and science, aerospace and defence, commercial and industrial markets. It offers components, sub-systems and associated services.
Eaga is a support services company concentrating on the implementation of energy efficiency into homes. Working for the government, local authorities and private homeowners it is the largest national supplier of heating and renewable energy solutions.
Eastern Platinum is a mid-tier platinum group metals (PGM) producer on the Bushveld Complex. It operates the flagship Crocodile River Mine on the western limb and is developing two near-term eastern limb projects: Mareesburg and Kennedy's Vale.
Founded in 1995, easyJet is one of Europe's largest low-cost, no-frills scheduled airlines with operating bases throughout the UK and mainland Europe. The company operates over 160 aircraft covering around 400 routes in more than 25 countries.
Eckoh provides a hosted speech recognition platform for the customer contact centre market. Eckoh also provides web, mobile and smartphone self-service applications.
ECR Minerals is a mineral development company with a substantial interest in THEMAC Resources Group, which is developing the Copper Flat copper project in New Mexico, and holdings in West Wits Mining, ACS Asia and Paniai Gold.
Edgewater Exploration is a Canadian-based mine development company focused on building a mid-tier gold company. Edgewater is aggressively advancing the 100%-owned Corcoesto gold project in Galicia, north-west Spain. The company also has a JV agreement with Kinross Gold on the Enchi gold project in south-west Ghana.
EFK Diagnostics has been assembled through the acquisition of four point of (PoC) care diagnostics businesses since 2010. It is particularly strong on blood analysis and also in PoC diabetes tests. Products are differentiated between high price and emerging markets giving a wide spread of risk in test types and markets.
Electrocomponents is a distributor of mechanical, electrical and electronic components to customers in industry. It operates globally via catalogue and website.
Elk Petroleum is an enhanced oil recovery (EOR) company. This technology achieves low-cost tertiary recovery of residual oil. Elk’s first project at Grieve in the US is targeted for first production in CY17. There is a significant opportunity to apply EOR in Australasia, Indonesia and Malaysia.
Elmos Semiconductor designs and manufactures ICs (integrated circuits) and MEMS (micro electro-mechanical systems) pressure sensors that are used in the automotive, industrial, consumer and medical sectors. Headquartered in Dortmund, it has sold over two billion silicon chips worldwide.
EMIS is a clinical software supplier to the primary care market in the UK, supplying over 50% of UK GP practices. EMIS also supplies software to UK pharmacies through its 78.9% stake in RX Systems Ltd.
Emulex is one of two dominant suppliers of interface hardware for the mature Fibre Channel SAN equipment market and is working around patent litigation to develop its position in the 10g Ethernet infrastructure market.
Endocyte is US biotech company developing small molecule drug conjugates for cancer and inflammatory disease. It has four drugs in clinical development: EC145 (ovarian, Phase III and NSCLC Phase II), EC0489, EC225 and EC17 (all Phase I, solid tumours).
Energy Fuels is a fully integrated producer of both uranium and vanadium. The company is the largest conventional producer, supplying approximately 25% of the uranium produced in the US. Energy Fuels also has an extensive list of permitted mines and development projects.
Enfis is a leader in the design, development and manufacture of high brightness, power efficient, light emitting diode (LED) arrays and smart light engines.
Entu is a specialty UK supplier of energy efficient home improvement products for the domestic market. It was admitted to AIM on 30 October 2014 via a 50% placing of existing shares.
Epigenomics is a German molecular diagnostics company focused on early detection of cancer. Its main product is Epi proColon, a blood-based DNA test for colorectal cancer that uses a sophisticated PCR assay to detect methylated copies of the septin9 gene.
EQS is a leading global provider of digital solutions for investor relations and corporate communications. Its solutions and services are provided to more than 7,000 clients worldwide.
eServGlobal develops mobile software solutions to support mobile financial services, with a focus on emerging markets. The company also has a share in the HomeSend international remittances hub, alongside MasterCard and BICS.
Esperion is developing therapeutics for elevated low-density lipoprotein cholesterol (LDL-C) and other cardiometabolic risk factors. Lead candidate ETC-1002 is in Phase II development in statin-intolerant and residual-risk hypercholesterolemia patients.
Esterline is a specialised manufacturing company principally serving aerospace and defence markets, which account for c 80% of total revenue. The remaining 20% is from the application of those technologies into industrial and high-tech markets including medical, rail, energy production and gaming.
Euromax Resources is a Canadian resource company focused on the acquisition and development of mineral-bearing assets in Southeast Europe. Its flagship asset, Ilovica-Shtuka, in Macedonia, is the subject of a recently completed DFS.
EAT is an investment company incorporated in the Netherlands and listed on the LSE and Euronext. It targets capital growth through investment in quoted small- and medium-sized companies in Europe (ex-UK), taking the HSBC Europe (ex-UK) Smaller Companies Index as benchmark. A high distribution policy has been adopted; dividends have been paid from a combination of income and capital.
The European Investment Trust (EUT) aims to achieve long-term capital growth through a diversified portfolio of continental European securities. The trust was launched in 1972 and management was transferred to Edinburgh Partners on 1 February 2010 following a tender process. The manager follows a disciplined, long-term value approach. The trust has an indefinite life and is not subject to a periodic continuation vote.
Evolva is a Swiss high tech fermentation company. It has a proprietary yeast technology platform, which it uses to create and manufacture high-value speciality molecules for nutritional and consumer products.
Evotec is a drug discovery business that provides outsourcing solutions to pharmaceutical companies, including Bayer, Boehringer Ingelheim, Janssen and Roche. It has operations in Germany, France, the UK and the US.
Exact Sciences is a US medical diagnostics company focused on colorectal cancer. The company has a proprietary non-invasive stool-based, molecular screening technology for the detection of colorectal cancer (CRC).
Exillon Energy is an independent oil producer with assets in northern Russia.